VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease

Biochemical and Biophysical Research Communications

Volumn 411, Issue 3, 2011, Pages 620-626

  Wang, Ping ^a   Xie, Zhao Hong ^a   Guo, Yu Ji ^b   Zhao, Cui Ping ^a   Jiang, Hao ^a   Song, Yan ^a   Zhu, Zheng Yu ^a   Lai, Chao ^a   Xu, Shun Liang ^a   Bi, Jian Zhong ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer disease; Angiogenesis; Cerebral hypoperfusion; Cognitive impairment; Vascular endothelial growth factor

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BROXURIDINE; CHOLINE ACETYLTRANSFERASE; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD34 SELECTION; CELL HOMING; COGNITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HIPPOCAMPUS; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS; MUS MUSCULUS;

EID: 79961129467     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.003     Document Type: Article

References (23)

1. Masters C.L., Cappai R., Barnham K.J., Villemagne V.L. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J. Neurochem. 2006, 97:1700-1725.
2. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118:103-113.
3. Kitaguchi H., Ihara M., Saiki H., Takahashi R., Tomimoto H. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease. Neurosci. Lett. 2007, 417:128-131.
4. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
5. Yang S.P., Bae D.G., Kang H.J., Gwag B.J., Gho Y.S., Chae C.B. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol. Aging 2004, 25:283-290.
6. Del Bo R., Ghezzi S., Scarpini E., Bresolin N., Comi G.P. VEGF genetic variability is associated with increased risk of developing Alzheimer's disease. J. Neurol. Sci. 2009, 283:66-68.
7. Zheng C., Skold M.K., Li J., Nennesmo I., Fadeel B., Henter J.I. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Biochem. Biophys. Res. Commun. 2007, 363:989-993.
8. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003, 34:383-394.
9. Zheng C., Nennesmo I., Fadeel B., Henter J.I. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 2004, 56:564-567.
10. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
11. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 2000, 156:965-976.
12. Kalaria R.N., Cohen D.L., Premkumar D.R., Nag S., LaManna J.C., Lust W.D. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res. Mol. Brain Res. 1998, 62:101-105.
13. Wang Y., Galvan V., Gorostiza O., Ataie M., Jin K., Greenberg D.A. Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. Brain Res. 2006, 1115:186-193.
14. Pati S., Orsi S.A., Moore A.N., Dash P.K. Intra-hippocampal administration of the VEGF receptor blocker PTK787/ZK222584 impairs long-term memory. Brain Res. 2009, 1256:85-91.
15. Cao L., Jiao X., Zuzga D.S., Liu Y., Fong D.M., Young D., During M.J. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 2004, 36:827-835.
16. Plaschke K., Staub J., Ernst E., Marti H.H. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp. Neurol. 2008, 214:285-292.
17. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 2003, 111:1843-1851.
18. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
19. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., Hicklin D.J., Zhu Z., Witte L., Crystal R.G., Moore M.A., Rafii S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 2001, 193:1005-1014.
20. Thau-Zuchman O., Shohami E., Alexandrovich A.G., Leker R.R. Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J. Cereb. Blood Flow Metab. 2010, 30:1008-1016.
21. Lunn J.S., Sakowski S.A., Kim B., Rosenberg A.A., Feldman E.L. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev. Neurobiol. 2009, 69:871-884.
22. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 2005, 14:207-221.
23. Burger S., Noack M., Kirazov L.P., Kirazov E.P., Naydenov C.L., Kouznetsova E., Yafai Y., Schliebs R. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Int. J. Dev. Neurosci. 2009, 27:517-523.